← Back to Search

Genetic Testing for Colorectal Cancer

Phase < 1
Waitlist Available
Led By Niloy J Samadder
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial studies how well a genetic test called pharmacogenomics works in directing the use of supportive care medications in patients with stage III-IV cancer.

Eligible Conditions
  • Colorectal Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Cutaneous Melanoma
  • Breast Cancer
  • Bile Duct Cancer
  • Genitourinary Cancers
  • Cancer
  • Pancreatic Cancer
  • Brain Cancer
  • Pancreatic Biliary Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in symptoms, quality of life (QOL), and perceptions about pharmacogenomics (PGx) testing
Secondary outcome measures
Malignant Neoplasms

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (pharmacogenomics testing)Experimental Treatment4 Interventions
Patients undergo one-time collection of saliva sample for pharmacogenomics testing. Patients also complete quality of life assessment at baseline and at 3 months after pharmacogenomics testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 2
~1730

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,956 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,587 Total Patients Enrolled
Niloy J SamadderPrincipal InvestigatorMayo Clinic
5 Previous Clinical Trials
2,868 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently open opportunities to partake in this scientific inquiry?

"Per the clinicaltrials.gov website, this trial is not presently taking on participants. The study was initially posted in May of 2019 and most recently updated in October 2022. While no candidates are being recruited for this specific medical experiment at present, there are over 10,000 other trials actively seeking volunteers as we speak."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer
Niloy Jewel (Jewel) Samadder 2019. "Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04067960.
~34 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top